Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Home-based Transcranial Direct Current Stimulation to Modulate Neural Networks and Promote Resilience

NCT06051071 is registered in ClinicalTrials.gov with Institut Guttmann as lead sponsor.

NCT NCT06051071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06051071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Home-based Transcranial Direct Current Stimulation to Modulate Neural Networks and Promote Resilience
Lead sponsor
Institut Guttmann
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2023
Completion date
December 31, 2023
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stress